Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Impairment and disability in 20 CIDP patients according to disease activity status.
Clinical Outcome of 50 Progressive Multiple Sclerosis Patients Treated with Cellular Therapy in Iraq.
Matrine regulates glutamate-related excitotoxic factors in experimental autoimmune encephalomyelitis.
Olig2-lineage cells preferentially differentiate into oligodendrocytes but their processes degenerate at the chronic demyelinating stage of proteolipid protein-overexpressing mouse.
Amyotrophic lateral sclerosis is not linked to multiple sclerosis in a population based study.
Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring.
Functional neuroimaging may quantify spinal cord demyelinating disease.
Diffusion tensor imaging of the trigeminal nerve in patients with trigeminal neuralgia due to multiple sclerosis.
Genome-wide association studies in neurology.
Midkine: an emerging target of drug development for treatment of multiple diseases.
Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis.
Feasibility and reproducibility of whole brain myelin water mapping in 4 minutes using fast acquisition with spiral trajectory and adiabatic T2prep (FAST-T2) at 3T.
Metaboreflex activity in multiple sclerosis patients.
The brain as 'immunoprecipitator' of serum autoantibodies against NMDAR1.
Optimal detection of infratentorial lesions with a combined dual-echo MRI sequence: "PT2".
Four Hours is Enough for Lactation Interruption After High-Dose Methylprednisolone Treatment in Multiple Sclerosis Mothers by Measuring Milk Cortisol Levels.
Enzyme activity assays for protein kinases: Strategies to identify active substrates.
Influence of myelinated retinal nerve fibers on retinal vessel density measurement with AngioVue OCT angiography.
Individual Assessment of Brain Tissue Changes in MS and the Effect of Focal Lesions on Short-Term Focal Atrophy Development in MS: A Voxel-Guided Morphometry Study.
Intrinsic third ventricular craniopharyngioma: A case report.
Cognition in Early Relapsing-Remitting Multiple Sclerosis: Consequences May Be Relative to Working Memory.
Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM Evaluation of: Gold R, Kappos L, Arnold D, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012;
The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach.
Interleukin-1β and Interleukin-1 Receptor Antagonist Appear in Grey Matter Additionally to White Matter Lesions during Experimental Multiple Sclerosis.
Evaluation of commercial antibodies against human sphingosine-1-phosphate receptor 1.

Pages